Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2023 Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2023 Earnings Call Transcript August 3, 2023

Intellia Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.4 EPS, expectations were $-1.32.

Operator: Good morning and welcome to the Intellia Therapeutics’ Second Quarter 2023 Earnings Conference Call. My name is Drew and I will be your conference operator today. Following formal remarks, we will open the call up for a question-and-answer session. This conference is being recorded...